Forschungs- & Entwicklungsinformationsdienst der Gemeinschaft - CORDIS

Informationen von Horizont-2020-Projekten und nun auch Berichtzusammenfassungen stehen jetzt auf CORDIS bereit. Alle H2020-Projekte können jetzt vom Offenen Datenportal der EU heruntergeladen werden.

My refinements


Download results of this page


Filtern nach:

Advanced search

Nach Projekten und Ergebnissen suchen

Results 1 - 10 of 874
Results/page:
12 3 4 5 6 7 8 9 10 > >| 
Development of high throughput in vivo oncogenomic screening strategies in acute leukaemia
ID: 249891
Anfangsdatum: 2010-05-01, Enddatum: 2016-04-30
Within a highly successful research environment, we will develop a state-of the-art high throughput functional in vivo oncogenicity assay, using mouse bone marrow transplant models of leukaemia to conclusively identify the important genetic changes involved in the development...
Programme: FP7-IDEAS-ERC
Record Number: 94300
Last updated on: 2016-10-31
Final Report Summary - ONCOGENOMICS (Development of high throughput in vivo oncogenomic screening strategies in acute leukaemia)
The main aim of this project was to develop new ways to identify genes that contribute to childhood acute lymphocytic leukaemia (ALL) through loss (tumour suppressor genes) or gain (oncogenes). To this end we devised assays where effects on growth or survival of leukaemia...
Programme: FP7-IDEAS-ERC
Record Number: 187784
Last updated on: 2016-08-17
Mid-Term Report Summary - STEMCARDIOVASC (Human Pluripotent Stem Cells: the new heart patient?)
Increases in life expectancy are being paralleled by increased prevalence of chronic, age- and lifestyle-associated disorders of the cardiovascular system. This has not been met by commensurate development of new drugs, in part because diseases like heart failure have been...
Programme: FP7-IDEAS-ERC
Record Number: 187755
Last updated on: 2016-08-23
Human Pluripotent Stem Cells: the new heart patient?
ID: 323182
Anfangsdatum: 2013-11-01, Enddatum: 2018-10-31
"The ability to generate pluripotent stem cells (iPSC) by reprogramming somatic tissues is arguably the greatest breakthrough in biomedical science of the last decade. The most inaccessible cells of the body can now be derived repeatedly from any individual. This could have a...
Programme: FP7-IDEAS-ERC
Record Number: 110774
Last updated on: 2015-03-11
Mid-Term Report Summary - META-GROWTH (Metabolic regulation of growth and body composition: key modulators of long-term health)
The ERC META-GROWTH project started in October 2013 to study key modulators of early programming mechanisms of infant growth and body composition. A strong team of post-doc researchers, statisticians, study nurses, technicians, PhD students and support staff has been...
Programme: FP7-IDEAS-ERC
Record Number: 187746
Last updated on: 2016-08-23
Metabolic regulation of growth and body composition: key modulators of long-term health
ID: 322605
Anfangsdatum: 2013-10-01, Enddatum: 2018-09-30
Nutrient exposure during pregnancy and childhood strongly affects growth and induces persistent metabolic programming of lifelong health. Recent data show that obesity and related disorders are induced by both fast childhood weight gain, and by formula feeding that promotes h...
Programme: FP7-IDEAS-ERC
Record Number: 109426
Last updated on: 2016-10-10
Multiparametric tumor imaging and beyond: Towards understanding in vivo signals
ID: 323196
Anfangsdatum: 2013-06-01, Enddatum: 2018-05-31
Non-invasive preclinical and clinical imaging is a powerful tool and has a huge potential, specifically in the realm of oncology. Recently, our laboratory developed a novel multimodality imaging system, which combines positron emission tomography (PET) and magnetic resonance ...
Programme: FP7-IDEAS-ERC
Record Number: 108354
Last updated on: 2016-03-31
Mid-Term Report Summary - IMAGELINK (Multiparametric tumor imaging and beyond: Towards understanding in vivo signals)
In this project we want to gain a deeper understanding of the information that we can generate with multiparametric imaging by linking imaging to proteomics and metabolomics. This will enable us to define the molecular underlyings of imaging phenotypes. To achieve this, we...
Programme: FP7-IDEAS-ERC
Record Number: 187716
Last updated on: 2016-08-23
Identification and functional validation of drugable targets/pathways for triple negative breast cancer
ID: 322737
Anfangsdatum: 2013-04-01, Enddatum: 2018-03-31
Patients suffering from triple-negative breast cancer (TNBC) have a poor prognosis as these tumors frequently confer resistance against chemotherapeutic agents and lack drug targets such as estrogen receptor, progesterone receptor, and epidermal growth factor receptor 2. Insu...
Programme: FP7-IDEAS-ERC
Record Number: 108208
Last updated on: 2016-03-31
Mid-Term Report Summary - TRIPLE-BC (Identification and functional validation of drugable targets/pathways for triple negative breast cancer)
Patients suffering from triple-negative breast cancer (TNBC) have a poor prognosis as these tumors frequently confer resistance against chemotherapeutic agents, and lack the known drug targets estrogen receptor, progesterone receptor and epidermal growth factor receptor-2...
Programme: FP7-IDEAS-ERC
Record Number: 187714
Last updated on: 2016-08-23
12 3 4 5 6 7 8 9 10 > >| 
List retrieved on: 2017-02-24